Doctors treating patient

NHS Trust to trial world’s first high blood pressure injection

The world’s first ever injection-based treatment for high blood pressure will be given to 100 trial patients over the next three years.

The study, with 630 total worldwide patients, will be run out of Barts Health NHS Trust in conjunction with Queen Mary University of London and will involve a long-acting injection being administered to patients once every six months.

The study is being backed by the National Institute for Health and Care Research (NIHR) and, if successful, could change how adults with high blood pressure are treated forever.

Dr Manish Saxena, study lead and Deputy Clinical Director at Queen Mary University of London, Hypertension Specialist at Barts Health NHS Trust said: “We are excited to be trialling this first of its kind approach to research if it is safe and effective for the treatment of high blood pressure."

He added: “Solving health challenges on this scale cannot be achieved by one person or entity alone. We are thrilled to be working alongside [partners] and combining our expertise to hopefully change modern medicine.”

Approximately a third of adults in the UK suffer from high blood pressure, with key risk factors including being overweight, a poor diet with excess salt and not enough fruit and vegetables, along with smoking and a lack of exercise. If left untreated high blood pressure can considerably increase the risk of heart attacks and strokes.

The drug the scientists will be using is called Zilebesiran, which is an investigational RNA interference (RNAi) therapeutic targeting angiotensinogen (AGT) – a protein produced by the liver and involved in regulating blood pressure. Zilebesiran is administered under the skin and is designed to inhibit the production of AGT preventing constriction of blood vessels which may help reduce elevated blood pressure.

Half of the people with high blood pressure in the UK aren’t diagnosed or receiving treatment, therefore providing a more diverse range of treatments will be beneficial to the population.

For more information on the study, click here.

National Health Executive, Jan/Feb, Cover

NHE Jan/Feb 22

The pioneering programmes aimed at solving the NHS workforce pressures - starting at the top

This issue highlights the latest topics within the health sector, from pioneering programmes aimed at solving the NHS workforce pressures, treatment to slow the progression of Parkinson's disease, how the UK is leading the way in cancer research & more!


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all